Homocysteine lowering treatment v placebo after percutaneous coronary interventionâ€
| Outcomes at 1 year | Homocysteine lowering | Placebo | RRR (95% CI) | NNT (CI) |
|---|---|---|---|---|
| †Composite outcome included death, cardiac death, nonfatal myocardial infarction, or need for repeated revascularisation. Abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article using Cox proportional hazards ratio. | ||||
| Composite outcome | 15.4% | 22.8% | 69% (50 to 97) | 15 (9 to 167) |
| Repeated revascularisation | 14.0% | 19.9% | 29% (1.8 to 46) | 18 (11 to 281) |
| Repeated target lesion revascularisation | 9.9% | 16.0% | 37% (4.6 to 57) | 17 (11 to 136) |